Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q3 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.